SWOT Analysis for Editas Medicine Inc

Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Increasing profits every quarter for the past 2 quarters
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding
Negative Breakdown First Support (LTP < S1)
Negative profit growth, promoters decreasing shareholding QoQ
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Weak Stocks (DVM)
Highest fall from 52 Week High
Top Losers
Negative Breakdown First Support (LTP < S1)
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Weak Momentum: Price below Short, Medium and Long Term Averages
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Top Losers